Daiichi-Sankyo is a global pharmaceutical company with corporate origins in Japan. Daiichi-Sankyo provides innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, the company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
www.Daiichi-Sankyo.com Daiichi-Sankyo Europe supports the Cardio Update Europe 2024 as a Premium Partner.
GSK makes innovative vaccines and specialty medicines to prevent and treat disease. Their R&D focuses on the science of the immune system, human genetics and advanced technologies.
www.GSK.com GSK supports the Cardio Update Europe 2024 as a Partner.
Inari Medical is dedicated to treating venous thromboembolism and transforming the lives of patients suffering from venous diseases by safely and effectively removing blood clots. We put our patients first and embrace the opportunity to celebrate patient stories.
www.inarimedical.com Inari Medical supports the Cardio Update Europe 2024 as a Gold Partner.
Medtronic is the global leader medical technology, alleviating pain, restoring health an extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies - every three seconds, another life is improved by a Medtronic product or therapy.
www.Medtronic.om Medtronic supports the Cardio Update Europe 2024 as a Partner.
Pharmacosmos is specialized in iron therapy. The company develops, manufactures and markets medicines for the treatment of iron deficiency anemia in humans and animals. Pharmacosmos is furthermore specialist in developing and producing advanced carbohydrates for pharmaceutical and technical uses.
www.pharmacosmos.com Pharmacosmos supports the Cardio Update Europe 2024 as a Partner.
